Open-source AI predicts key peptide traits before costly lab testing
Engineers at the University of Pennsylvania have developed PeptiVerse, an open-source AI platform designed to predict the chemical and biological properties of peptides. This tool aims to streamline drug discovery by allowing researchers to evaluate potential treatments before committing to expensive laboratory synthesis.
Why it matters
It could significantly reduce the time and financial costs associated with developing new peptide-based medications, such as those used for weight loss.
by Ian Scheffler, University of Pennsylvania
edited by Lisa Lock , reviewed by Robert Egan
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add as preferred source A laptop running PeptiVerse, at left, next to machines used to synthesize peptides, center and at right. Researchers can use PeptiVerse to predict the properties of peptides before incurring the time and expense required to synthesize them. Credit: Sylvia Zhang, Penn Engineering Penn Engineers have developed PeptiVerse , an AI-powered platform that predicts key chemical and biological properties of peptides, strings of amino acids whose medical potential has been demonstrated by the success of GLP-1 drugs, widely used weight-loss treatments.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in